163 related articles for article (PubMed ID: 25345911)
1. Interstitial lung disorders in the indium workers of Korea: an update study for the relationship with biological exposure indices.
Choi S; Won YL; Kim D; Lee MY; Choi YJ; Park JS; Kim HR; Jung JI; Lee SG; Kim EA
Am J Ind Med; 2015 Jan; 58(1):61-8. PubMed ID: 25345911
[TBL] [Abstract][Full Text] [Related]
2. Exposure to hardly soluble indium compounds in ITO production and recycling plants is a new risk for interstitial lung damage.
Hamaguchi T; Omae K; Takebayashi T; Kikuchi Y; Yoshioka N; Nishiwaki Y; Tanaka A; Hirata M; Taguchi O; Chonan T
Occup Environ Med; 2008 Jan; 65(1):51-5. PubMed ID: 17626138
[TBL] [Abstract][Full Text] [Related]
3. Possibility of lung cancer risk in indium-exposed workers: An 11-year multicenter cohort study.
Nakano M; Omae K; Tanaka A; Hirata M
J Occup Health; 2019 May; 61(3):251-256. PubMed ID: 30895696
[TBL] [Abstract][Full Text] [Related]
4. Interstitial pulmonary disorders in indium-processing workers.
Chonan T; Taguchi O; Omae K
Eur Respir J; 2007 Feb; 29(2):317-24. PubMed ID: 17050566
[TBL] [Abstract][Full Text] [Related]
5. Five-year cohort study: emphysematous progression of indium-exposed workers.
Nakano M; Omae K; Uchida K; Michikawa T; Yoshioka N; Hirata M; Tanaka A
Chest; 2014 Nov; 146(5):1166-1175. PubMed ID: 24946105
[TBL] [Abstract][Full Text] [Related]
6. Subclinical interstitial lung damage in workers exposed to indium compounds.
Choi S; Won YL; Kim D; Yi GY; Park JS; Kim EA
Ann Occup Environ Med; 2013 Oct; 25(1):24. PubMed ID: 24472147
[TBL] [Abstract][Full Text] [Related]
7. Early changes in clinical, functional, and laboratory biomarkers in workers at risk of indium lung disease.
Cummings KJ; Virji MA; Trapnell BC; Carey B; Healey T; Kreiss K
Ann Am Thorac Soc; 2014 Nov; 11(9):1395-403. PubMed ID: 25295756
[TBL] [Abstract][Full Text] [Related]
8. Analytical and Clinical Performance of the Nanopia Krebs von den Lungen 6 Assay in Korean Patients With Interstitial Lung Diseases.
Cho EJ; Park KJ; Ko DH; Koo HJ; Lee SM; Song JW; Lee W; Lee HK; Do KH; Chun S; Min WK
Ann Lab Med; 2019 May; 39(3):245-251. PubMed ID: 30623616
[TBL] [Abstract][Full Text] [Related]
9. High levels of indium exposure relate to progressive emphysematous changes: a 9-year longitudinal surveillance of indium workers.
Amata A; Chonan T; Omae K; Nodera H; Terada J; Tatsumi K
Thorax; 2015 Nov; 70(11):1040-6. PubMed ID: 26286723
[TBL] [Abstract][Full Text] [Related]
10. Causal relationship between indium compound inhalation and effects on the lungs.
Nakano M; Omae K; Tanaka A; Hirata M; Michikawa T; Kikuchi Y; Yoshioka N; Nishiwaki Y; Chonan T
J Occup Health; 2009; 51(6):513-21. PubMed ID: 19834281
[TBL] [Abstract][Full Text] [Related]
11. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
Ma H; Lu J; Song Y; Wang H; Yin S
BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
[TBL] [Abstract][Full Text] [Related]
12. Indium lung--case reports and epidemiology.
Omae K; Nakano M; Tanaka A; Hirata M; Hamaguchi T; Chonan T
Int Arch Occup Environ Health; 2011 Jun; 84(5):471-7. PubMed ID: 20886351
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary effects in workers exposed to indium metal: A cross-sectional study.
Nakano M; Tanaka A; Hirata M; Iwasawa S; Omae K
J Occup Health; 2015; 57(4):346-52. PubMed ID: 25958975
[TBL] [Abstract][Full Text] [Related]
14. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
15. Serial evaluations at an indium-tin oxide production facility.
Cummings KJ; Suarthana E; Edwards N; Liang X; Stanton ML; Day GA; Saito R; Kreiss K
Am J Ind Med; 2013 Mar; 56(3):300-7. PubMed ID: 23109040
[TBL] [Abstract][Full Text] [Related]
16. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia.
Ichiyasu H; Ichikado K; Yamashita A; Iyonaga K; Sakamoto O; Suga M; Kohrogi H
Respiration; 2012; 83(3):190-7. PubMed ID: 21555868
[TBL] [Abstract][Full Text] [Related]
17. Two-year follow-up of exposure, engineering controls, respiratory protection and respiratory health among workers at an indium-tin oxide (ITO) production and reclamation facility.
Harvey RR; Virji MA; Blackley BH; Stanton ML; Trapnell BC; Carey B; Healey T; Cummings KJ
Occup Environ Med; 2022 Aug; 79(8):550-556. PubMed ID: 35414568
[TBL] [Abstract][Full Text] [Related]
18. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
[TBL] [Abstract][Full Text] [Related]
20. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
